Today: 7 March 2026
Subscribe
Browse Category

Stock Market 17 November 2025

Canadian Solar (CSIQ) Stock Soars on Storage Deals, Roth Price Target Hike & Insider Sales – November 17, 2025

Canadian Solar (CSIQ) Stock Soars on Storage Deals, Roth Price Target Hike & Insider Sales – November 17, 2025

Canadian Solar shares surged over 60% in November, hitting a 12-month high of $34.59 after Q3 earnings beat expectations. Roth Capital raised its price target to $30, but the average Wall Street target remains below the current $29–30 level. New deals in Canada and Germany and insider sales filings drew attention on November 17. The company reported Q3 revenue of about $1.5 billion and an adjusted EPS loss of $0.58.
17 November 2025
··
E.W. Scripps (SSP) Soars as Sinclair Builds 8.2% Stake and Pushes for Takeover on November 17, 2025

E.W. Scripps (SSP) Soars as Sinclair Builds 8.2% Stake and Pushes for Takeover on November 17, 2025

Sinclair Inc. revealed an 8.2% stake in The E.W. Scripps Company on Nov. 17, 2025, and confirmed ongoing merger talks, pushing SSP shares up over 20%. Scripps’ board said it will protect shareholders and stick to its strategic plan. Sinclair claims the deal would bring $300 million in annual cost synergies without external financing. The proposed merger would combine more than 230 local TV stations.
17 November 2025
···
Medical Properties Trust (MPW) Hikes Dividend 12% and Extends Buyback Push: What Investors Need to Know Today (17 November 2025)

Medical Properties Trust (MPW) Hikes Dividend 12% and Extends Buyback Push: What Investors Need to Know Today (17 November 2025)

Medical Properties Trust raised its quarterly dividend to $0.09 per share, up 12% from $0.08, payable January 8, 2026 to shareholders of record December 11. The announcement follows a $150 million stock buyback plan and recent Q3 results showing a net loss but higher revenue. MPW shares traded near $5.18, up 4.5% on the day, with a market cap around $3 billion.
17 November 2025
·
Sociedad Química y Minera (SQM) Soars as Lithium Rebounds and Codelco JV Gets Final Green Light

Sociedad Química y Minera (SQM) Soars as Lithium Rebounds and Codelco JV Gets Final Green Light

SQM shares surged about 12% Monday in New York, hitting a 52-week high near $61 after China approved its lithium joint venture with Codelco. Major funds including Itaú Unibanco and KBC Group disclosed new or larger stakes. Lithium prices rose on signs of stronger Chinese demand. Investors await SQM’s Q3 2025 earnings report due Tuesday.
17 November 2025
···
PACS Group (PACS) Stock Soars as Company Pledges to Clear SEC Filing Backlog by November 19, 2025

PACS Group (PACS) Stock Soars as Company Pledges to Clear SEC Filing Backlog by November 19, 2025

PACS Group shares surged nearly 50% to $15.90 Monday after the company said it will file all overdue SEC reports and release Q3 2025 earnings on November 19. The filings aim to resolve delisting and default risks tied to a months-long reporting backlog. PACS confirmed a $61–65 million overstatement in 2024 Medicare Part B revenue, citing an ongoing audit probe. Trading volume topped 4.3 million shares by late morning.
17 November 2025
·
ZIM Integrated Shipping (NYSE: ZIM) Jumps Toward $17 as Bulltick Boosts Stake Ahead of Q3 Earnings – November 17, 2025

ZIM Integrated Shipping (NYSE: ZIM) Jumps Toward $17 as Bulltick Boosts Stake Ahead of Q3 Earnings – November 17, 2025

ZIM shares jumped about 6% to $17 late morning Monday as traders positioned ahead of Thursday’s Q3 earnings report. Bulltick Wealth Management increased its stake by 33% to 88,000 shares. Options markets priced in an 11–12% move post-earnings, signaling volatility. Today is also the record date for ZIM’s December 19 shareholder meeting in Haifa.
17 November 2025
··
Pfizer (PFE) Stock Today, November 17, 2025: Migraine Drug Launch in India, Metsera Deal Closes and New RSV Vaccine Data

Pfizer (PFE) Stock Today, November 17, 2025: Migraine Drug Launch in India, Metsera Deal Closes and New RSV Vaccine Data

Pfizer launched Rimegepant ODT, a migraine tablet, in India, targeting a $200 million market. Shares traded near $25.28, down 55% from late 2022, with a dividend yield around 7%. Analysts maintain a “Hold” rating and see limited short-term movement. The new product addresses migraine in adults unresponsive to standard treatments.
17 November 2025
··
GameStop Stock (GME) on November 17, 2025: Retail Buzz, ‘Trade Anything Day’ Hype and New Short‑Squeeze Speculation

GameStop Stock (GME) on November 17, 2025: Retail Buzz, ‘Trade Anything Day’ Hype and New Short‑Squeeze Speculation

GameStop shares traded around $20.70 late Monday morning, up slightly after hitting a new 52-week low of $18.89 last week. The stock remains down 34% year-to-date despite recent profitable quarters and a viral “Trade Anything Day” promotion. Short interest is near a 12-month high, fueling debate among retail traders over valuation and short-squeeze potential.
17 November 2025
·
Rivian Stock (RIVN) Today: Price Targets Raised, Battery Bug Emerges and Big Holders Trim Stakes – November 17, 2025

Rivian Stock (RIVN) Today: Price Targets Raised, Battery Bug Emerges and Big Holders Trim Stakes – November 17, 2025

Rivian shares traded near $15.06 early afternoon November 17, down 0.3% after a surge of over 30% post-Q3 earnings. The company reported its first positive gross profit, while Stifel and Tigress Financial raised price targets. Headlines flagged a battery calibration bug in R1 models, and filings showed major investors and CEO RJ Scaringe selling shares. Volume topped 14 million.
17 November 2025
··
Tesla (TSLA) News Today: China Supply Chain Shake-Up, Thiel Trims Stake, AI5 Delay and Divided Wall Street – 17 November 2025

Tesla (TSLA) News Today: China Supply Chain Shake-Up, Thiel Trims Stake, AI5 Delay and Divided Wall Street – 17 November 2025

Tesla shares rose about 2.5% to $414.46 on November 17 after Elon Musk ordered U.S. suppliers to phase out China-made parts within two years. Peter Thiel cut his Tesla stake by over 75% in Q3. Musk said the next-gen AI5 chip is delayed until mid-2027. Wall Street remains split on robotaxi prospects, with price targets ranging from $131 to $509.
17 November 2025
··
Ford Stock Soars in 2025 as Wall Street Backs EV Reset, Hybrids and an Amazon-Powered Digital Pivot

Ford Stock Soars in 2025 as Wall Street Backs EV Reset, Hybrids and an Amazon-Powered Digital Pivot

Ford shares have surged about 32–37% in 2025, outpacing the S&P 500 and trading near a 52-week high around $13.20. Wall Street cites Ford’s shift away from costly EV projects toward profitable trucks and hybrids, despite ongoing multi-billion-dollar EV losses. Analyst targets average $11.73, with most maintaining a “Hold” rating. The stock’s dividend yield remains near 4.5%.
17 November 2025
···
Opendoor (OPEN) News Today: Warrant Dividend, Short Seller Crackdown and Wall Street Caution — November 17, 2025

Opendoor (OPEN) News Today: Warrant Dividend, Short Seller Crackdown and Wall Street Caution — November 17, 2025

Opendoor Technologies shares traded at $8.03 on November 17, down 1% after recent highs above $10. The company’s controversial warrant dividend, set for distribution on November 21, targets short sellers and has fueled volatility. Morgan Stanley maintained a Hold rating, while quants noted large hedge fund flows. Opendoor stock remains up several hundred percent year-to-date.
17 November 2025
··
Beyond Meat (BYND) Stock News Today, November 17, 2025: Class Action Probe, Meme-Stock Hangover and Heavy Dilution Risks

Beyond Meat (BYND) Stock News Today, November 17, 2025: Class Action Probe, Meme-Stock Hangover and Heavy Dilution Risks

Beyond Meat shares traded near $1.08 Monday after law firm Bleichmar Fonti & Auld LLP announced a new securities-fraud investigation into the company. The probe centers on whether Beyond Meat misled investors about asset values and impairment charges. Short interest has dropped to 13.2%, its lowest since early 2021. The stock remains down about 70% for the year.
17 November 2025
·
Galmed Pharmaceuticals (GLMD) Soars on New Cancer Drug Combo Data: What Today’s Breakthrough Means for Investors – November 17, 2025

Galmed Pharmaceuticals (GLMD) Soars on New Cancer Drug Combo Data: What Today’s Breakthrough Means for Investors – November 17, 2025

Galmed Pharmaceuticals reported that a triple-drug combination of Aramchol, Stivarga, and metformin sharply increased tumor cell killing in GI cancer models. Shares jumped as much as 38.6% premarket and traded around $1.18 by afternoon, with volume exceeding 41 million shares. The company plans a Phase 1b trial at VCU Massey Comprehensive Cancer Center in early 2026. New U.S. patent applications have been filed for the combination.
17 November 2025
···
Autonomix Medical (AMIX) Stock Doubles on New Pancreatic Cancer Quality‑of‑Life Data – November 17, 2025 Update

Autonomix Medical (AMIX) Stock Doubles on New Pancreatic Cancer Quality‑of‑Life Data – November 17, 2025 Update

Autonomix Medical reported 20–30-point gains in quality-of-life scores at three months in a subgroup analysis from its PoC 1 study for severe pancreatic cancer pain. Even Stage 4 patients saw durable symptom and function improvements after nerve ablation. AMIX shares nearly doubled intraday on heavy volume, ranking among Nasdaq’s top gainers. The company remains pre-revenue and highly volatile.
17 November 2025
··
MSP Recovery (MSPR) Stock Jumps Over 20% Pre‑Market as Q3 Delay and Nasdaq Fight Keep Volatility High – 17 November 2025

MSP Recovery (MSPR) Stock Jumps Over 20% Pre‑Market as Q3 Delay and Nasdaq Fight Keep Volatility High – 17 November 2025

MSP Recovery (MSPR) surged as much as 40% in pre-market trading on November 17, 2025, reaching $0.62 after closing at $0.45 on Friday. The spike came amid heavy volume and no new company news, as traders responded to recent volatility, a late Q3 filing, and ongoing Nasdaq delisting risk. Market cap remains below $1 million, with the company facing a $1.56 billion net loss in 2024 and a $1.2 billion debt restructuring.
17 November 2025
··
Twin Vee PowerCats (VEEE) Stock Jumps in Premarket as Bahama Boats Roll Out: Latest News for 17 November 2025

Twin Vee PowerCats (VEEE) Stock Jumps in Premarket as Bahama Boats Roll Out: Latest News for 17 November 2025

Twin Vee PowerCats (NASDAQ: VEEE) jumped as much as 22% in pre-market trading Monday, hitting $2.15 before dropping to around $1.73 by early afternoon. The move followed recent news on Bahama Boat Works deliveries and Q3 results showing narrower losses. No new filings or press releases appeared Monday. Trading volume and volatility spiked despite no fresh catalyst.
17 November 2025
·
WeShop Holdings (NASDAQ: WSHP) Soars Again as Nasdaq Composite Adds New Social‑Commerce Stock – 17 November 2025 Update

WeShop Holdings (NASDAQ: WSHP) Soars Again as Nasdaq Composite Adds New Social‑Commerce Stock – 17 November 2025 Update

WeShop Holdings (NASDAQ: WSHP) surged as much as 95% in pre-market trading on November 17, reaching nearly $60 after a 92% jump on its debut Friday. The stock was added to the Nasdaq Composite Index just days after listing. Pre-market volume topped 32,000 shares, with market cap estimates near $1.03 billion. Trading feeds showed extreme volatility, with prices fluctuating between $47 and $60.
17 November 2025
··
Cypherpunk Technologies (CYPH) Soars Over 300% on Zcash Pivot – What’s Driving Today’s Volatile Rally? (17 November 2025)

Cypherpunk Technologies (CYPH) Soars Over 300% on Zcash Pivot – What’s Driving Today’s Volatile Rally? (17 November 2025)

Cypherpunk Technologies (NASDAQ: CYPH) shares jumped over 30% in U.S. pre-market trading Monday, reaching about $3.60 and a $155 million market cap. The move follows last week’s rebrand from Leap Therapeutics and a $50 million Zcash purchase backed by Winklevoss Capital. CYPH stock has surged more than 300% since its Nasdaq debut under the new ticker on November 13.
17 November 2025
··
1 … 1,172 1,173 1,174 1,175 1,176 … 1,337
Go toTop